Literature DB >> 16027957

Validation of OSTA among Filipinos.

Julie T Li-Yu1, Lyndon J Q Llamado, Tito P Torralba.   

Abstract

Osteoporosis is the most common metabolic bone disease in humans. It is a special concern not only among postmenopausal women, but men as well. In developing countries where there are meager resources, it will definitely be helpful to search for ways to identify patients with low bone mineral density who have a high risk of future fractures. These people need to be identified for treatment consideration in order to reduce the incidence of the disease and its complications. A simple risk index called the Osteoporosis Screening Tool for Asians (OSTA), based only on two variables, age and body weight, performed well in identifying the risk of osteoporosis among postmenopausal women. This index has been validated in Japan, Korea and other Caucasian populations as a useful tool in identifying individuals who will require BMD measurement. This is the first study that validated the said index in 1,597 Filipino women and men referred to a tertiary center for BMD measurement. It had sensitivity of 97 and 90% and specificity of 59 and 66% with areas under the curve of 0.8506 and 0.8475, respectively, for women and men. We conclude that OSTA performed just as well or even better than other indices used in other populations to identify individuals who are at varying degrees of risk for osteoporosis. The tool also proves to be a useful and practical guide to help clinicians to be more prudent and judicious in employing bone mineral density measurement.

Entities:  

Mesh:

Year:  2005        PMID: 16027957     DOI: 10.1007/s00198-005-1929-x

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  5 in total

1.  Validation of the simple calculated osteoporosis risk estimation (SCORE) for patient selection for bone densitometry.

Authors:  S M Cadarette; S B Jaglal; T M Murray
Journal:  Osteoporos Int       Date:  1999       Impact factor: 4.507

2.  Development and validation of the Osteoporosis Risk Assessment Instrument to facilitate selection of women for bone densitometry.

Authors:  S M Cadarette; S B Jaglal; N Kreiger; W J McIsaac; G A Darlington; J V Tu
Journal:  CMAJ       Date:  2000-05-02       Impact factor: 8.262

3.  A simple tool to identify asian women at increased risk of osteoporosis.

Authors:  L K Koh; W B Sedrine; T P Torralba; A Kung; S Fujiwara; S P Chan; Q R Huang; R Rajatanavin; K S Tsai; H M Park; J Y Reginster
Journal:  Osteoporos Int       Date:  2001       Impact factor: 4.507

4.  Factors related to the use of bone densitometry: survey responses of 494 primary care physicians in New England.

Authors:  D H Solomon; M T Connelly; C J Rosen; B Dawson-Hughes; D P Kiel; S L Greenspan; E S Leib; M Holick; A H Miguel; J S Finkelstein
Journal:  Osteoporos Int       Date:  2003-03-14       Impact factor: 4.507

5.  Bone mineral measurements in mice: comparison of two devices.

Authors:  Sami Kolta; Marie-Christine De Vernejoul; Pierre Meneton; Jacques Fechtenbaum; Christian Roux
Journal:  J Clin Densitom       Date:  2003       Impact factor: 2.963

  5 in total
  20 in total

Review 1.  Systematic review and meta-analysis of the performance of clinical risk assessment instruments for screening for osteoporosis or low bone density.

Authors:  S Nayak; D L Edwards; A A Saleh; S L Greenspan
Journal:  Osteoporos Int       Date:  2015-02-03       Impact factor: 4.507

2.  [Evaluation of screening accuracy on osteoporosis self-assessment tool for Asians and its cut-off value in healthy physical examination population].

Authors:  P Wang; H Wu; Y Che; D W Fan; J Liu; L Y Tao
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2019-12-18

3.  Performance of the osteoporosis risk assessment tool in Moroccan men.

Authors:  Mirieme Ghazi; Aziza Mounach; Abderrazak Nouijai; Imad Ghozlani; Loubna Bennani; Lahsen Achemlal; Ahmed Bezza; Abdellah El Maghraoui
Journal:  Clin Rheumatol       Date:  2007-04-03       Impact factor: 2.980

4.  The correlation between the oral glucose tolerance test 30-minutes plasma glucose and risk factors for diabetes and cardiovascular diseases: a cross-sectional epidemiological study of diabetes in Fujian Province in the South-East of China.

Authors:  G Chen; X Zou; J Yao; Q Jiang; Y Zhang; M Tu; S Yang; S Xu; W Lin; H Huang; J Liang; L Li; L Lin
Journal:  J Endocrinol Invest       Date:  2010-10-08       Impact factor: 4.256

5.  Development and validation of osteoporosis risk-assessment model for Korean postmenopausal women.

Authors:  Sun Min Oh; Byung-Ho Nam; Yumie Rhee; Seong-Hwan Moon; Deog Young Kim; Dae Ryong Kang; Hyeon Chang Kim
Journal:  J Bone Miner Metab       Date:  2013-02-19       Impact factor: 2.626

6.  Diagnostic value of osteoporosis self-assessment tool for Asians (OSTA) and quantitative bone ultrasound (QUS) in detecting high-risk populations for osteoporosis among elderly Chinese men.

Authors:  Xiao-Yun Zha; Yu Hu; Xiao-Na Pang; Gui-Lin Chang; Li Li
Journal:  J Bone Miner Metab       Date:  2014-04-20       Impact factor: 2.626

7.  Sensitivity of osteoporosis screening guidelines for eventual hip fracture in older male veterans.

Authors:  Juliessa M Pavon; Linda L Sanders; Richard Sloane; Cathleen Colón-Emeric
Journal:  Bonekey Rep       Date:  2014-05-07

8.  Selecting men for bone densitometry: performance of osteoporosis risk assessment tools in Portuguese men.

Authors:  P Machado; M Coutinho; J A P da Silva
Journal:  Osteoporos Int       Date:  2009-09-02       Impact factor: 4.507

9.  Osteoporosis Self-Assessment Tool for Asians Can Predict Neurologic Prognosis in Patients with Isolated Moderate Traumatic Brain Injury.

Authors:  Chia-Hung Chao; Yu-Feng Su; Hon-Man Chan; Shiuh-Lin Huang; Chih-Lung Lin; Aij-Lie Kwan; Yun-Ting Lou; Chao-Wen Chen
Journal:  PLoS One       Date:  2015-07-17       Impact factor: 3.240

10.  Development and Validation of Osteoporosis Risk-Assessment Model for Korean Men.

Authors:  Sun Min Oh; Bo Mi Song; Byung Ho Nam; Yumie Rhee; Seong Hwan Moon; Deog Young Kim; Dae Ryong Kang; Hyeon Chang Kim
Journal:  Yonsei Med J       Date:  2016-01       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.